Compound ID | 2062
Synonym(s): Silver sulfadiazine (salt of sulphadiazine)
Class: Antibacterial sulfonamide (sulfa drug)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Sulphonamides are structural analogues of p-aminobenzoic acid and act as competitive inhibitors (and alternate substrates) of dihydropteroate synthase (DHPS) to block the synthesis of folic acid. Primarily bacteriostatic; rapid emergence of resistance. Silver sulfadizine is water insoluble and acts as a combination of silver and sulfadizine. |
Description: | Synthetic sufanilamide derivative; intermediate-acting (8-12 hours). Oral and topical use (silver sulfadiazine, especially for infected burns). |
Year first mentioned: | 1941 |
Development status: | Approved, off-patent |
Chemical structure(s): | |
Canonical SMILES: | C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N |
Isomeric SMILES: | C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N |
InChI: | InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14) |
InChI Key: | SEEPANYCNGTZFQ-UHFFFAOYSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/5215 |
External links: | |
Guide to Pharmacology: | sulfadiazine |
Main Source: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2601063/pdf/yjbm00510-0025.pdf |
Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046889/ |